Evolution of Renal Function with Early Everolimus-Facilitated Reduction or Elimination of Tacrolimus in 719 De Novo Liver Transplant Recipients: 12 Month Data of the H2304 Study

被引:0
|
作者
De Simone, P.
Nevens, F.
De Carlis, L.
Metselaar, H. J.
Beckebaum, S.
Saliba, F.
Jonas, S.
Sudan, D.
Fischer, L.
Duvoux, C.
Foltys, D.
Koneru, B.
Wang, Y. [1 ]
Hexham, J. M. [1 ]
Junge, G. [1 ]
Fung, J.
机构
[1] Novartis Pharma AG, Basel, Switzerland
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
705
引用
收藏
页码:238 / 238
页数:1
相关论文
共 50 条
  • [1] Impact of Early Everolimus-Facilitated Reduction or Elimination of Tacrolimus on the Evolution of Renal Function in 719 De Novo Liver Transplant Recipients: 12 Month Data of the H2304 Study
    Metselaar, H. J.
    Saliba, F.
    Schemmer, P.
    Foltys, D.
    Fabregat, J.
    Ericzon, B. -G.
    Dong, G.
    Hexham, J. M.
    Junge, G.
    De Simone, P.
    [J]. TRANSPLANTATION, 2012, 94 (10) : 44 - 44
  • [2] Everolimus with Early Reduction or Elimination of Tacrolimus in 719 De Novo Liver Transplant Recipients-12 Month Efficacy and Safety Results from H2304 Study
    Fung, J.
    Nevens, F.
    De Carlis, L.
    Metselaar, H. J.
    Beckebaum, S.
    Saliba, F.
    Jonas, S.
    Sudan, D.
    Fischer, L.
    Duvoux, C.
    Chavin, K. D.
    Koneru, B.
    Jiang, H.
    Hexham, J. M.
    Junge, G.
    De Simone, P.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 28 - 28
  • [3] Renal Function with Everolimus and Reduced Tacrolimus in De Novo Liver Transplant Recipients: 12 Month Results of the H2304 Study
    De Simone, P.
    Nevens, F.
    De Carlis, L.
    Metselaar, H. J.
    Beckebaum, S.
    Saliba, F.
    Jonas, S.
    Sudan, D.
    Fischer, L.
    Foltys, D.
    Koneru, B.
    Wang, Y.
    Hexham, J. M.
    Junge, G.
    Fung, J.
    [J]. LIVER TRANSPLANTATION, 2012, 18 : S85 - S86
  • [4] EVEROLIMUS WITH EARLY REDUCTION OR ELIMINATION OF TACROLIMUS: 12 MONTH RESULTS OF A RANDOMIZED, CONTROLLED STUDY IN 719 DE NOVO LIVER TRANSPLANT RECIPIENTS
    Nevens, F.
    De Carlis, L.
    Metselaar, H.
    Saliba, F.
    Beckebaum, S.
    Jonas, S.
    Sudan, D.
    Fischer, L.
    Fung, J.
    Jiang, H.
    Junge, G.
    De Simone, P.
    [J]. JOURNAL OF HEPATOLOGY, 2012, 56 : S551 - S552
  • [5] Everolimus-Facilitated Tacrolimus Minimization Preserves Renal Function in De Novo Renal Transplant Recipients
    Shihab, F.
    Qazi, Y.
    Kaplan, B.
    Kim, D.
    Mulgaonkar, S.
    Peddi, V.
    Shaffer, D.
    Patel, D.
    McCague, K.
    Vincenti, F.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 538 - 539
  • [6] Everolimus-Facilitated Tacrolimus Minimization Preserves Renal Function in De Novo Renal Transplant Recipients.
    Shihab, F.
    Qazi, Y.
    Kaplan, B.
    Kim, D.
    Mulgaonkar, S.
    Peddi, V.
    Shaffer, D.
    Patel, D.
    McCague, K.
    Vincenti, F.
    [J]. TRANSPLANTATION, 2014, 98 : 538 - 539
  • [7] Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation
    Chapman, William C.
    Brown, Robert S.
    Chavin, Kenneth D.
    Sudan, Debra
    Koneru, Baburao
    Junge, Guido
    Dong, Gaohong
    Patel, Dharmesh
    Teperman, Lewis
    Fung, John J.
    [J]. TRANSPLANTATION, 2017, 101 (02) : 341 - 349
  • [8] RANDOMIZED, MULTICENTER STUDY OF EVEROLIMUS WITH EARLY REDUCTION OR ELIMINATION OF TACROLIMUS IN 719 DE NOVO LIVER TRANSPLANT RECIPIENTS: RESULTS AT 12 MONTHS
    Saliba, Faouzi
    Duvoux, Christophe
    Durand, Francois
    Neau-Cransac, Martine
    Hardwigsen, Jean
    Pageaux, Georges
    Boleslawski, Emmanuel
    [J]. TRANSPLANT INTERNATIONAL, 2012, 25 : 39 - 39
  • [9] Efficacy and Safety of Everolimus with Early Reduction or Elimination of Tacrolimus in 719 de Novo Liver Transplant Recipients - Results at 12 Months
    De Simone, P.
    Nevens, F.
    Duvoux, C.
    Koneru, B.
    McCormack, L.
    McCaughan, G.
    Navasa, M.
    Dong, G.
    Hexham, J. M.
    Junge, G.
    Fung, J.
    [J]. TRANSPLANTATION, 2012, 94 (10) : 750 - 750
  • [10] Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial
    Nashan, Bjorn
    Schemmer, Peter
    Braun, Felix
    Dworak, Markus
    Wimmer, Peter
    Schlitt, Hans
    [J]. TRIALS, 2015, 16